PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer – results of a multicentre UK evaluation

Claire Cuerden; Charlotte Gower; Kevin Brown; Paul T Heath; Nick Andrews; Gayatri Amirthalingam; Jessica Bate

doi:10.1136/archdischild-2022-324396

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

For authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

Original research

PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer – results of a multicentre UK evaluation

Free

Online download statistics by month:

Online download statistics by month: July 2022 to February 2023

	Abstract	Full	Pdf
Jul 2022	3771	133	70
Aug 2022	245	20	20
Sep 2022	113	19	8
Oct 2022	558	495	69
Nov 2022	444	447	73
Dec 2022	226	216	32
Jan 2023	173	171	34
Feb 2023	206	205	25
Total	5736	1706	331

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: July 2022 to February 2023

Read the full text or download the PDF:

Log in using your username and password